Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

Filippou G, Pezzoni L, Filippucci E, Tedeschi SK, Pascart T, Adinolfi A, Cipolletta E, Jauffret C, Sirotti S, Abhishek A, Albert D, Andres M, Baraf H, Becce F, Bertrand J, Biernat-Kaluza E, Castelar-Pinheiro GDR, Dehlin M, Diaz-Torne C, Doherty M, Fields TR, FitzGerald J, Gancheva R, Grainger R, Kumar N, Kwok T, Latourte A, Liew J, Louthrenoo W, Mandl P, Manigold T, McCarthy G, Möller I, Naredo E, Neogi T, Niessink T, Ottaviani S, Parperis K, Perez-Ruiz F, Pineda C, Porta F, Roddy E, Rosenthal A, Schlesinger N, Sivera F, Stamp L, Tai V, Tausche AK, Terslev L, Towiwat P, Uhlig T, Vreju FA, Yin C, Terkeltaub R, Dalbeth N. Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD). Ann Rheum Dis. 2026 Jun 9:S0003-4967(26)00298-0. doi: 10.1016/j.ard.2026.05.019. Epub ahead of print. PMID: 42264993.


Related Posts